KFDA to enforce tough penalty against drugs recalls.

Published: 2005-11-08 06:59:00

Updated: 2005-11-08 06:59:00

The KFDA explained about the new provision that would be enforced from March next year in the meeting of "the recall for the drugs of no quality test pass" at KPMA on Nov. 2 that the company should be penalized with one month business suspension if the company failed to recall the drugs of no qua...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK